Use access key #2 to skip to page content.
$72.74 -0.29 (-0.40%)
11/21/2008 4:01 PM

Genentech, Inc. (DNA)

CAPS Rating:
*****

The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.

View All Commentary (DNA)

Recs

1

Avatar topsailonmymind (26.77) Submitted: 4/08/07 7:24 PM : Outperform Start Price: $83.40 DNA Score: 34.79

Genetech has been the leader in the Biotech industry. Thye have a great pipeline. Corporate culture continues to foster innovation and development. Leadership is solid. Good fundamentals and projected growth rates (21 analysts with avg projected growth rates of 16 to 41% mean of analysts is 26%).

Biotech has been beaten down but will continue to grow s more prodcuts are devloped and reach market. Over next 10 to 20 years it will be a critical contributor to healthcare of the world.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links